Male partners of infertile couples with congenital unilateral absence of the vas deferens are mainly non-azoospermic.
Adult
Azoospermia
/ epidemiology
Cystic Fibrosis Transmembrane Conductance Regulator
/ genetics
Female
Humans
Infertility, Male
/ etiology
Male
Male Urogenital Diseases
/ complications
Middle Aged
Oligospermia
/ epidemiology
Pregnancy
Retrospective Studies
Sperm Count
Vas Deferens
/ abnormalities
Young Adult
CFTR mutations
infertility
seminal plasma
sperm count
vas deferens
Journal
Andrology
ISSN: 2047-2927
Titre abrégé: Andrology
Pays: England
ID NLM: 101585129
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
14
08
2019
revised:
11
12
2019
accepted:
16
12
2019
pubmed:
25
12
2019
medline:
26
5
2021
entrez:
25
12
2019
Statut:
ppublish
Résumé
Men with congenital unilateral absence of vas deferens were reported to be mainly azoospermic, with both unilateral renal absence and mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) but some have neither. To assess whether in infertile couples the male partners with congenital unilateral absence of vas deferens are mainly azoospermic men. Retrospective study in a unique university hospital; reproductive, clinical, CFTR analysis and seminal data of male partners of infertile couples (from 1998 to 2018) were analysed. Diagnosis of congenital unilateral absence of vas deferens was based on transrectal ultrasounds (TRUS): complete or partial absence of one vas deferens with complete contralateral vas deferens confirmed in 63 men. Distribution of sperm count in three classes: azoospermia, oligozoospermia or normozoospermia. Ultrasound determination of renal status; seminal biomarkers assays; and search for CFTR mutations. Among the 63 men, 39.7% displayed azoospermia, 27% oligozoospermia and 33.3% normozoospermia; 42% of the non-azoospermic men (16/38) had previously obtained a natural pregnancy. We found unilateral renal absence in 17/59 patients (29%). Among 50 men with CFTR testing, five carried an allele associated with cystic fibrosis belonging to the 29 men without renal anomalies, indicating a high allelic frequency (8.6%). The 63 patients displayed high rates of surgical histories for undescended testicles or inguinal hernia, low values of semen volume and of total seminal glycerophosphocholine. Our results indicate that men with congenital unilateral absence of vas deferens mainly display oligozoospermia or normozoospermia and that they were previously fertile. They clearly confirm, first, that CFTR testing is recommended in congenital unilateral absence of vas deferens men and it should be mandatory for those with normal kidneys; and, second, that TRUS is needed for the diagnosis of congenital unilateral absence of vas deferens. As congenital unilateral absence of vas deferens may be present whatever the sperm count, biological warnings are represented by semen volume and seminal epididymal markers and clinical warnings by surgical histories of undescended testes or inguinal hernia.
Sections du résumé
BACKGROUND
Men with congenital unilateral absence of vas deferens were reported to be mainly azoospermic, with both unilateral renal absence and mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) but some have neither.
OBJECTIVES
To assess whether in infertile couples the male partners with congenital unilateral absence of vas deferens are mainly azoospermic men.
MATERIAL AND METHODS
Retrospective study in a unique university hospital; reproductive, clinical, CFTR analysis and seminal data of male partners of infertile couples (from 1998 to 2018) were analysed. Diagnosis of congenital unilateral absence of vas deferens was based on transrectal ultrasounds (TRUS): complete or partial absence of one vas deferens with complete contralateral vas deferens confirmed in 63 men. Distribution of sperm count in three classes: azoospermia, oligozoospermia or normozoospermia. Ultrasound determination of renal status; seminal biomarkers assays; and search for CFTR mutations.
RESULTS
Among the 63 men, 39.7% displayed azoospermia, 27% oligozoospermia and 33.3% normozoospermia; 42% of the non-azoospermic men (16/38) had previously obtained a natural pregnancy. We found unilateral renal absence in 17/59 patients (29%). Among 50 men with CFTR testing, five carried an allele associated with cystic fibrosis belonging to the 29 men without renal anomalies, indicating a high allelic frequency (8.6%). The 63 patients displayed high rates of surgical histories for undescended testicles or inguinal hernia, low values of semen volume and of total seminal glycerophosphocholine.
CONCLUSIONS
Our results indicate that men with congenital unilateral absence of vas deferens mainly display oligozoospermia or normozoospermia and that they were previously fertile. They clearly confirm, first, that CFTR testing is recommended in congenital unilateral absence of vas deferens men and it should be mandatory for those with normal kidneys; and, second, that TRUS is needed for the diagnosis of congenital unilateral absence of vas deferens. As congenital unilateral absence of vas deferens may be present whatever the sperm count, biological warnings are represented by semen volume and seminal epididymal markers and clinical warnings by surgical histories of undescended testes or inguinal hernia.
Substances chimiques
CFTR protein, human
0
Cystic Fibrosis Transmembrane Conductance Regulator
126880-72-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
645-653Informations de copyright
© 2019 American Society of Andrology and European Academy of Andrology.
Références
Miller S, Couture S, James G, Plourde S, Rioux J, Labrecque M. Unilateral absence of vas deferens: prevalence among 23,013 men seeking vasectomy. Int Braz J Urol. 2016;42:1010-1017.
Akinsal EC, Baydilli N, Dogan ME, Ekmekcioglu O. Comorbidity of the congenital absence of the vas deferens. Andrologia. 2018. https://doi.org/10.1111/and.12844
Casals T, Bassas L, Egozcue S, et al. Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens. Hum Reprod. 2000;15:1476-1483.
Donohue RE, Fauver H. Unilateral absence of the vas deferens-a useful clinical sign. JAMA. 1989;261:1180-1182.
Kolettis PN, Sandlow JY. Clinical and genetic features of patients with congenital unilateral absence of the vas deferens. Urology. 2002;60:1073-1076.
Mickle J, Milunsky A, Amos JA, Oates RD. Congenital unilateral absence of the vas deferens: a heterogeneous disorder with two distinct subpopulations based upon aetiology and mutational status of the cystic fibrosis gene. Hum Reprod. 1995;10:1728-1735.
Schlegel PN, Shin D, Goldstein M. Urogenital anomalies in men with congenital absence of the vas deferens. J Urol. 1996;155:1644-1648.
Weiske WH, Salzler N, Schroeder-Printzen I, Weidner W. Clinical findings in congenital absence of the vasa deferentia. Andrologia. 2000;32:13-18.
Dumur V, Gervais R, Rigot JM, et al. Abnormal distribution of CF delta F508 allele in azoospermic men with congenital aplasia of epididymis and vas deferens. Lancet. 1990;336(8713):512.
Ratbi I, Legendre M, Niel F, et al. Detection of cystic fibrosis transmembrane conductance regulator (CFTR) gene rearrangements enriches the mutation spectrum in congenital bilateral absence of the vas deferens and impacts on genetic counselling. Hum Reprod. 2007;22:1285-1291.
Patat O, Pagin A, Siegfried A, et al. Truncating mutations in the adhesion G protein-coupled receptor G2 gene ADGRG2 cause an X-linked congenital bilateral absence of vas deferens. Am J Hum Genet. 2016;99:437-442.
Meschede D, Dworniczak B, Nieschlag E, Horst J. Genetic diseases of the seminal ducts. Biomed Pharmacother. 1998;52:197-203.
Schwarzer JU, Schwarz M. Significance of CFTR gene mutations in patients with congenital aplasia of vas deferens with special regard to renal aplasia. Andrologia. 2012;44:305-307.
Cornud F, Belin X, Delafontaine AT, Hélénon O, Moreau JF. Imaging of obstructive azoospermia. Eur Radiol. 1997;7:1079-1085.
World Health Organization. WHO laboratory manual for the examination of human semen and sperm cervical mucus interactions, 4th edn. Cambridge, UK: Cambridge University Press; 1999. https://www.who.int/reproductivehealth/publications/infertility/0521774748/en/
World Health Organization. WHO laboratory manual for the examination and processing of human semen, 5th edn. Geneva, Switzerland: World Health Organization; 2010. http://www.who.int/reproductivehealth/publications/infertility/9789241547789/en/
Wagenknecht LV, Lotzin CF, Sommer H-J, Schirren C. Vas deference aplasia: Clinical and anatomical features of 90 cases. Prog reprod Biol Med. 1985;12:162-174.
Van Assche E, Bonduelle M, Tournaye H, et al. Cytogenetics of infertile men. Hum Reprod. 1996;11(Suppl 4):1-26.
Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature. 2003;423:825-837.
Hall S, Oates RD. Unilateral absence of the scrotal vas deferens associated with contralateral mesonephric duct anomalies resulting in infertility: laboratory, physical and radiographic findings, and therapeutic alternatives. J Urol. 1993;150:1161-1164.
Sharma N, Acharya N, Singh SK, Singh M, Sharma U, Prasad R. Heterogenous spectrum of CFTR gene mutations in Indian patients with congenital absence of vas deferens. Hum Reprod. 2009;24:1229-1236.
Daudin M, Bieth E, Bujan L, Massat G, Pontonnier F, Mieusset R. Congenital bilateral absence of the vas deferens: clinical characteristics, biological parameters, cystic fibrosis transmembrane conductance regulator gene mutations, and implications for genetic counselling. Fertil Steril. 2000;74:1164-1174.
Augarten A, Yahav Y, Kerem BS, et al. Congenital bilateral absence of vas deferens in the absence of cystic fibrosis. Lancet. 1994;344(8935):1473-1474.
de la Taille A, Rigot JM, Mahe P, et al. Correlation between genito-urinary anomalies, semen analysis and CFTR genotype in patients with congenital bilateral absence of the vas deferens. Prog Urol. 1998;8:370-376.
McCallum TJ, Milunsky JM, Munarriz R, Carson R, Sageghi-Nejad H, Oates RD. Unilateral renal agenesis associated with congenital bilateral absence of the vas deferens: phenotypic findings and genetic considerations. Hum Reprod. 2001;16:282-288.
Bobadilla JL, Macek M Jr, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat. 2002;19:575-606.
Estivill X, Bancells C, Ramos C. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium. Hum Mutat. 1997;10:135-154.
Jungwirth A, Diemer T, Kopa Z, Krausz C, Tournaye H. EAU Guidelines on Male Infertility. http://uroweb.org/wp-content/uploads/17-Male-Infertility_2017_web.pdf
Akinsal EC, Baydilli N, Imamoglu H, Ekmekcioglu O. Three cases of Klinefelter's syndrome with unilateral absence of vas deferens. Andrologia. 2017;49:e12844.
Virtanen HE, Bjerknes R, Cortes D, et al. Cryptorchidism: classification, prevalence and long-term consequences. Acta Paediat. 2007;96:611-616.
Bronsther B, Abrams MW, Elboim C. Inguinal hernias in children- A study of 1,000 cases and a review of the literature. J Am Med Wom Assoc. 1972;27:522-535.
Cai H, Qing X, Damascene Niringiyumukiza J, et al. CFTR variants and renal abnormalities in males with congenital unilateral absence of the vas deferens (CUAVD): a systematic review and meta-analysis of observational studies. Genet Med. 2019;21:826-836.
Glezerman M, Bartoov B. Semen analysis. In: Insler V, Lunenfeld B, eds. Infertility: Male and Female, 2nd edn. Livingstone, NY, USA: Churchill; 1993:285-315.